Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUY922 weekly intravenous dose-escalation study with breast cancer expansion cohorts
2006-002766-20Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Luminespib in Non-hematologic malignancy and breast cancer (3 arms), sponsored by Novartis. Started May 2008; status: completed.
02
Drugs
Luminespib
03
Conditions
Non-hematologic malignancybreast cancer
Beyond the preview
Go deeper on 2006-002766-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002766-20.